Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2019, QantX is a venture capital firm based in Bristol, UK, dedicated to addressing the underfunding of spinouts from local universities. The firm focuses on early-stage companies, particularly those involved in high-impact innovation. QantX aims to support the commercialization of research, contributing to economic growth and job creation in the South and South West of England.
As of now, QantX manages a £300 million fund and has backed 17 companies through equity and grants. The firm has established strong ties with the SETsquared Partnership, which includes universities such as Bristol, Bath, Exeter, and Surrey. This collaboration enhances QantX's ability to foster innovation and development in the region.
QantX's notable milestones include the announcement of a new £300 million investment vehicle in October 2024, aimed at supporting innovative startups in the South West. The firm operates from multiple locations, including Bristol, Exeter, and Truro, and is committed to driving regional economic development.
QantX primarily invests in early-stage companies at the Pre-seed and Seed stages, with check sizes ranging from £0 to £750,000. The firm targets sectors such as healthcare, biotechnology, artificial intelligence, and sustainability. Its investment strategy is centered on addressing global challenges through innovative solutions.
The firm seeks IP-rich startups that are often university spinouts, focusing on three core themes: Zero Carbon, Modern Healthcare, and Deep Technology. QantX looks for companies that can provide novel biologics, point-of-care diagnostics, and improved patient pathways in healthcare, as well as sustainability technologies that contribute to a balanced future.
QantX emphasizes patient capital, offering not just financial support but also expertise and connections to help portfolio companies thrive. The firm’s strong university partnerships enhance its ability to identify and support promising startups in the South and South West of England.
QantX has built a diverse portfolio of 17 companies, focusing on innovative solutions across various sectors. Notable portfolio companies include:
These companies exemplify QantX's commitment to supporting high-impact innovation in healthcare and sustainability, addressing significant global challenges.
Richard Haycock: Co-Founder and CEO of QantX, Richard has extensive experience in venture capital and startup development. He has been instrumental in building QantX's portfolio and fostering university partnerships.
Sir Richard Olver: Co-Founder and Chairman, Sir Richard has a background in leadership roles at BP and GKN. His expertise in corporate governance and strategic development adds significant value to QantX.
Roger Killen: Investment Partner, Roger brings a wealth of experience in investment management and has been involved in numerous successful funding rounds.
Dr. Harry Alexander: Investment Manager, Dr. Harry specializes in evaluating healthcare innovations and has a strong background in life sciences.
Dame Vivienne Cox: Investment Advisor, Dame Vivienne has held leadership positions in various organizations and provides strategic guidance to QantX.
Dr. Elizabeth O'Driscoll: Investment Advisor, Dr. Elizabeth has expertise in biotechnology and supports QantX in identifying promising investment opportunities.
To pitch to QantX, founders should use the contact email enquiries@qantx.co.uk or visit their website at qantx.co.uk. It is recommended to include a comprehensive business plan, highlighting the team, technology, and market opportunity. QantX prefers detailed decks that clearly outline the startup's vision and strategy.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory.
In October 2024, QantX announced a new £300 million investment vehicle aimed at supporting innovative startups in the South West of England. This fund is in partnership with the SETsquared universities, enhancing QantX's ability to back university spinouts.
Recent investments include companies like Neuronostics and SENISCA, which focus on healthcare innovations. QantX continues to expand its portfolio, actively seeking out startups that address significant global challenges.
What are QantX's investment criteria?
QantX invests in early-stage companies at the Pre-seed and Seed stages, focusing on sectors such as healthcare, biotechnology, artificial intelligence, and sustainability. The firm seeks IP-rich startups, particularly those that are university spinouts, and typically invests up to £750,000 per company.
How can I apply or pitch to QantX?
Founders can pitch to QantX by visiting their website at qantx.co.uk and using the contact email enquiries@qantx.co.uk. It is advisable to include a detailed business plan and information about the team and technology in the pitch.
What makes QantX different from other venture capital firms?
QantX differentiates itself through its strong ties with local universities and its focus on addressing the underfunding of university spinouts. The firm provides patient capital, expertise, and connections to help startups succeed in their commercialization efforts.
What is QantX's geographic scope?
QantX primarily focuses on the South and South West of England, investing in companies that are based in or have strong connections to this region.
What is QantX's post-investment involvement like?
QantX actively supports its portfolio companies through mentorship, operational support, and access to its network. The firm aims to enhance the growth potential of its investments by providing ongoing guidance and resources.
What is the size of QantX's fund?
QantX manages a £300 million fund, which was announced in October 2024, aimed at supporting innovative startups in the South West of England.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.